Close Menu

KBioscience

LGC Genomics said last week that it has expanded its nucleic acid extraction services to North America through the group's genomics laboratory in Beverly, Mass.
The new extraction service will complement existing capacity in Berlin and London, LGC said.

LGC Genomics, a division of the UK-based LGC Group that provides DNA and genetic analysis services, recently expanded its genotyping facilities to keep up with its sequencing-based SNP discovery services.

KBioscience develops genotyping assays using a fluorescence-based competitive allele-specific PCR technique that it calls KASP.

LGC Buys KBioscience

LGC's Genomics division and KBioscience will be combined to offer genomic services and solutions.

Many more plant and animal-themed SNP chips are expected to become available soon for organisms as diverse as wheat, horse, avocado, and catfish.

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.